OptiNose Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters05-15

OptiNose Inc reports results for the quarter ended March 31 - Earnings Summary

OptiNose Inc OPTN.OQ reported a quarterly adjusted loss of $1.92 per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of $-1.80. The lone analyst forecast for the quarter was for a loss of 74 cents per share.
Revenue rose 24.4% to $18.51 million from a year ago; analysts expected $17.70 million.
OptiNose Inc's reported EPS for the quarter was a loss of $1.92.
OptiNose Inc shares had risen by 3.1% this quarter and gained 41.5% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 1.3% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
Wall Street's median 12-month price target for OptiNose Inc is $9.00

This summary was machine generated from LSEG data May 15 at 02:39 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING	ESTIMATE	ACTUAL	BEAT, MET, MISSED
Mar. 31 2025	-0.74	-1.92	Missed
Dec. 31 2024	-0.71	-0.03	Beat
Sep. 30 2024	-0.79	0.00	Beat
Jun. 30 2024	-1.16	-0.75	Beat

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2535830760?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-15 10:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2535830760","market":"nz","top_or_hot":-1,"title":"OptiNose Inc reports results for the quarter ended March 31 - Earnings Summary","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>OptiNose Inc reports results for the quarter ended March 31 - Earnings Summary</title></head><body><ul><li><p>OptiNose Inc <span>OPTN.OQ</span> reported a quarterly adjusted loss of $1.92 per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of $-1.80.  The lone analyst forecast for the quarter was for a loss of 74 cents per share. </p></li><li><p>Revenue rose 24.4% to $18.51 million from a year ago; analysts expected $17.70 million. </p></li><li><p>OptiNose Inc's reported EPS for the quarter was a loss of $1.92.</p></li><li><p>OptiNose Inc shares had risen by 3.1% this quarter and gained 41.5% so far this year.</p></li></ul><p>FORECAST CHANGES</p><ul><li><p>The mean earnings estimate of analysts had risen by about 1.3% in the last three months. </p></li><li><p>In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.</p></li></ul><p>RECOMMENDATIONS</p><ul><li><p>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" 3 \"hold\" and no \"sell\" or \"strong sell.\" </p></li><li><p>Wall Street's median 12-month price target for OptiNose Inc is $9.00 </p></li></ul><p>This summary was machine generated from LSEG data May 15 at 02:39 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p><table><tbody><tr><td><p>QUARTER ENDING</p></td><td><p>ESTIMATE </p></td><td><p>ACTUAL</p></td><td><p>BEAT, MET, MISSED</p></td></tr><tr><td><p>Mar. 31 2025 </p></td><td><p>-0.74</p></td><td><p>-1.92</p></td><td><p>Missed</p></td></tr><tr><td><p>Dec. 31 2024 </p></td><td><p>-0.71</p></td><td><p>-0.03</p></td><td><p>Beat</p></td></tr><tr><td><p>Sep. 30 2024 </p></td><td><p>-0.79</p></td><td><p>0.00</p></td><td><p>Beat</p></td></tr><tr><td><p>Jun. 30 2024 </p></td><td><p>-1.16</p></td><td><p>-0.75</p></td><td><p>Beat</p></td></tr></tbody></table></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OptiNose Inc reports results for the quarter ended March 31 - Earnings Summary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOptiNose Inc reports results for the quarter ended March 31 - Earnings Summary\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-05-15 10:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>OptiNose Inc reports results for the quarter ended March 31 - Earnings Summary</title></head><body><ul><li><p>OptiNose Inc <span>OPTN.OQ</span> reported a quarterly adjusted loss of $1.92 per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of $-1.80.  The lone analyst forecast for the quarter was for a loss of 74 cents per share. </p></li><li><p>Revenue rose 24.4% to $18.51 million from a year ago; analysts expected $17.70 million. </p></li><li><p>OptiNose Inc's reported EPS for the quarter was a loss of $1.92.</p></li><li><p>OptiNose Inc shares had risen by 3.1% this quarter and gained 41.5% so far this year.</p></li></ul><p>FORECAST CHANGES</p><ul><li><p>The mean earnings estimate of analysts had risen by about 1.3% in the last three months. </p></li><li><p>In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.</p></li></ul><p>RECOMMENDATIONS</p><ul><li><p>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" 3 \"hold\" and no \"sell\" or \"strong sell.\" </p></li><li><p>Wall Street's median 12-month price target for OptiNose Inc is $9.00 </p></li></ul><p>This summary was machine generated from LSEG data May 15 at 02:39 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p><table><tbody><tr><td><p>QUARTER ENDING</p></td><td><p>ESTIMATE </p></td><td><p>ACTUAL</p></td><td><p>BEAT, MET, MISSED</p></td></tr><tr><td><p>Mar. 31 2025 </p></td><td><p>-0.74</p></td><td><p>-1.92</p></td><td><p>Missed</p></td></tr><tr><td><p>Dec. 31 2024 </p></td><td><p>-0.71</p></td><td><p>-0.03</p></td><td><p>Beat</p></td></tr><tr><td><p>Sep. 30 2024 </p></td><td><p>-0.79</p></td><td><p>0.00</p></td><td><p>Beat</p></td></tr><tr><td><p>Jun. 30 2024 </p></td><td><p>-1.16</p></td><td><p>-0.75</p></td><td><p>Beat</p></td></tr></tbody></table></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OPTN","symbol_name":"Optinose Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nL8N3RN01G:1","article_id":"2535830760","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2535830760","pubTimestamp":1747276801,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"OptiNose Inc reports results for the quarter ended March 31 - Earnings SummaryOptiNose Inc OPTN.OQ reported a quarterly adjusted loss of $1.92 per share for the quarter ended March 31, lower than the ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"OPTN":"Optinose Inc."},"translate_title":"OptiNose Inc报告截至3月31日的季度业绩-收益摘要","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OPTN":0.9},"content_text":"OptiNose Inc reports results for the quarter ended March 31 - Earnings SummaryOptiNose Inc OPTN.OQ reported a quarterly adjusted loss of $1.92 per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of $-1.80.  The lone analyst forecast for the quarter was for a loss of 74 cents per share. Revenue rose 24.4% to $18.51 million from a year ago; analysts expected $17.70 million. OptiNose Inc's reported EPS for the quarter was a loss of $1.92.OptiNose Inc shares had risen by 3.1% this quarter and gained 41.5% so far this year.FORECAST CHANGESThe mean earnings estimate of analysts had risen by about 1.3% in the last three months. In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.RECOMMENDATIONSThe current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" 3 \"hold\" and no \"sell\" or \"strong sell.\" Wall Street's median 12-month price target for OptiNose Inc is $9.00 This summary was machine generated from LSEG data May 15 at 02:39 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)QUARTER ENDINGESTIMATE ACTUALBEAT, MET, MISSEDMar. 31 2025 -0.74-1.92MissedDec. 31 2024 -0.71-0.03BeatSep. 30 2024 -0.790.00BeatJun. 30 2024 -1.16-0.75Beat","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535830760","isCrawlerRequest":true}